Having trouble accessing articles? Reset your cache.

Schrödinger, Beam are latest to post gains after pricing larger-than-expected IPOs

A pair of biotechs posted double-digit gains Thursday after upsizing their offerings and pricing at or above expectations, suggesting a sustained investor appetite for new biotech listings.

Schrödinger Inc. (NASDAQ:SDGR) gained $11.64 (68%) to $28.64 Thursday after

Read the full 374 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers